Cathie Wood's ARK Invest added to Figma (FIG) and trimmed DraftKings (DKNG) on Feb. 19, as part of a broader portfolio reshuffle.ARK funds bought about $24 mill

Recursion Pharmaceuticals (NASDAQ: RXRX - Get Free Report) is projected to issue its Q4 2025 results before the market opens on Friday, February 27th. Analysts expect the company to announce earnings of ($0.28) per share and revenue of $24.5570 million for the quarter. Parties are encouraged to explore the company's upcoming Q4 2025 earning overview page

In the most recent trading session, Recursion Pharmaceuticals (RXRX) closed at $3.53, indicating a +2.02% shift from the previous trading day.

Recursion Pharmaceuticals Inc (NASDAQ: RXRX) shares are under pressure Wednesday after new regulatory filings showed that Nvidia Corp (NASDAQ: NVDA) has fully exited its investment in the AI‑focused drug‑discovery company. Here's what you should know.

Company to host public (L)earnings call on February 25 at 8:00 am ET / 6:00 am MT / 1:00 pm GMT Company to host public (L)earnings call on February 25 at 8:00 am ET / 6:00 am MT / 1:00 pm GMT

Nvidia disclosed in a filing on Tuesday that it no longer held shares in Applied Digital, drug-discovery company Recursion Pharmaceuticals and autonomous-driving company WeRide.

AI-assisted drug discovery isn't just science fiction anymore, especially as biotechnology and biopharma firms embrace the AI age.

Transaction Overview On December 31, 2025, Baillie Gifford (Trades, Portfolio) executed a strategic transaction involving Recursion Pharmaceuticals Inc (RXRX).

Recursion Pharmaceuticals (RXRX) closed the most recent trading day at $3.85, moving 3.27% from the previous trading session.

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX - Get Free Report) have earned a consensus rating of "Hold" from the six research firms that are presently covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and two have given a buy rating